choose content

Choose content

Enter keywords to create a newsletter
create account

Create account

Enter your registration information
set preferences

Set preferences

Set up your newsletter name, delivery and time zone preferences
Hint: Enter different keywords to generate new results.

Now you can:

  1. Search the news index.
  2. Browse more than 1 million newsletters by category.
  3. Use preset newsletters:
    • Bridion

Bridion Newsletter
  • Human medicines European public assessment report (EPAR): Sugammadex Amomed, sugammadex, Date of authorisation: 10/01/2023, Revision: 2, Status: Authorised 23 Sep 2024 15:33 GMT

    … supervision of an anaesthetist (a doctor specialised in anaesthesia). Sugammadex Amomed … package leaflet or contact your doctor or pharmacist. How does Sugammadex … carried out with the reference medicine, Bridion, and do not need to …

  • Merck's 3Q Revenues up 4% 01 Nov 2024 16:35 GMT

    … competition. Bridion sales were flat at $420 million. Covid-19 drug Lagevrio …

  • 2023 First Generic Drug Approvals 08 Mar 2024 22:36 GMT

    … Package B. Braun Medical, Inc. Calcium Gluconate … once-daily, maintenance treatment of bronchospasm associated … Aspiro Pharma Limited Bridion (Sugammadex) Injection 6 … 0.064% Glenmark Pharmaceuticals LimitedGlenmark Pharmaceuticals Limited Enstilar ( …

  • Merck’s Bridion Could Face Generic Pressure from Hikma Ahead of Patent Expiry Date 27 Feb 2024 13:37 GMT

    … Monday that Hikma Pharmaceuticals U.S. is seeking the FDA’s approval … relaxant reversal injection Bridion (sugammadex) prior to the drug’s patent expiration … new and innovative treatments to patients with unmet medical needs. Tristan Manalac …

  • The biotech $100-billion Club: Meet the 14 most valuable drug makers 05 Mar 2024 23:47 GMT

    … S. Food and Drug Administration (FDA) for the treatment of one-year- … -drug conjugates for cancer, among others. Vertex Pharmaceuticals – $112 billion The American biotech … , Bridion, Adempas, Lagevrio, Belsomra, Simponi, and Januvia, as well as vaccines such …

  • Merck's Bridion faces generic threat from drugmaker Hikma 26 Feb 2024 23:13 GMT

    … received a letter that Hikma Pharmaceuticals US unit has sought … FDA to sell a generic version of its Bridion injection, the drugmaker … related to the brand-name drug. Merck said in the … to Reuters requests for comment. Bridion, chemically known as sugammadex, …

  • Merck 4Q Growth Driven by Oncology, Vaccines 05 Feb 2024 18:07 GMT

    … $14.5 billion (-97%) Comments: Pharmaceutical sales were $13.1 billion … driven by growth in oncology, vaccines and hospital acute care, … virology, due to COVID-19 vaccine LAGEVRIO, and diabetes. LAGEVRIO … pricing in the U.S. BRIDION sales were $429 million, …

  • 20 Most Expensive Drugs in the World 28 Dec 2023 03:40 GMT

    … drugs for numerous treatments, resulting in the expansion of the pharmaceutical drug … biotech companies, Roche Holding AG (ROG.SW) focuses on creating medicines … for the HPV vaccine in China. Additionally, … anti-muscle relaxant Bridion, reaching $1.7 billion …

  • Merck Secures Bridion Patent Protection Through January 2026 15 Jun 2023 15:24 GMT

    … muscle relaxant reversal medicine Bridion (sugammadex). In the medical and pharmaceutical industry, patents are … a drug candidate or investigational device goes through the FDA’s … new and innovative medicines and vaccines to address unmet medical needs and …

  • Merck gets a patent win for muscle relaxant reversal drug 14 Jun 2023 21:48 GMT

    … keep mar­ket­ing a block­buster surgery drug un­til ear­ly 2026. The phar­ma … a new drug. “We look for­ward to con­tin­u­ing to pro­vide Brid­ion to …

Satisfied with the content?

Continue to create your account.